Project Grant HT94252310648
Award Date
8/1/23
Completion Date
7/31/26
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
This federal Project Grant award of $1,485,001.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research conducted by the University of Alabama at Birmingham (UAB) to overcome perturbations that orchestrate immune exhaustion and dysfunction in breast cancer. The project aims to advance scientific understanding and develop innovative solutions in this critical area of biomedical research, with potential to transform...
The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
This $633,376 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Alabama at Birmingham (UAB) on September 1, 2023. The grant supports epigenome editing research to reactivate the FOXP3 gene in breast cancer tumors, with the goal of developing new treatments. The research project is scheduled for completion by August 31, 2026. UAB is a public research university known for its interdisciplinary...
This Project Grant award of $1,177,716.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports research at the University of Alabama at Birmingham (UAB) to investigate the "Metabolic Regulation of Metastatic Potential Through mRNA Translation." The award, which began on July 15, 2024 and will run through July 14, 2028, aims to advance scientific understanding of cancer metastasis through the study of metabolic processes and...
This federal Project Grant award of $227,167.00, issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research at the University of Alabama at Birmingham (UAB) focused on developing macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The award, with a performance period from July 1, 2025 to June 30, 2028, will enable UAB researchers to explore innovative approaches to...
The University of Alabama at Birmingham (UAB) was awarded a $650,845 federal Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on July 1, 2025, will support UAB's research into developing macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. This research aims to transform healthcare for military service members and the broader public by advancing innovative approaches...
The University of Alabama at Birmingham (UAB) was awarded a $1,485,000.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to improve the oncolytic immunovirotherapy of malignant glioma by targeting the glioma secretome. The 3-year grant was awarded on September 30, 2023 and is set to conclude on September 29, 2026. UAB is a public research university known for its innovative and interdisciplinary approach to education, and it...
The University of Alabama at Birmingham (UAB) was awarded a $1,317,584 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from July 1, 2025 to June 30, 2028, will support UAB's research on "Macrophage-Centric Prognostic Biomarkers for Checkpoint Blockade Immunotherapy in Melanoma." The project aims to develop innovative prognostic biomarkers and advance the...
The Department of the Army Medical Command awarded a $525,799 Project Grant to the University of Alabama to support its "TARGETING GPNMB TO IMPROVE EFFICACY OF CDK4/6 INHIBITORS IN ER+ BREAST CANCER" research project under the Military Medical Research and Development (CFDA 12.420) federal grant program. This program funds advanced biomedical research initiatives focused on transforming healthcare for military service members and the general public. The University of Alabama will...
The University of Alabama at Birmingham (UAB) received a $1,599,981.00 Project Grant award from the Defense Health Agency on June 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to activate immune reserves and prevent secondary bacterial lung infections after trauma and hemorrhage. This biomedical research project aims to improve health outcomes for military service members and the broader public. The project will be conducted over a...